Evolus Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:EOLS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 Mar 24	SellUS$86,431	David Moatazedi	Individual	6,236	US$13.86
19 Mar 24	SellUS$1,344,604	David Moatazedi	Individual	96,566	US$13.92
19 Mar 24	SellUS$78,978	Sandra Beaver	Individual	5,672	US$13.92
19 Mar 24	SellUS$384,350	Rui Avelar	Individual	27,603	US$13.92
22 Feb 24	SellUS$100,804	David Moatazedi	Individual	7,706	US$13.08
08 Dec 23	SellUS$822,396	David Moatazedi	Individual	82,648	US$10.09
16 Oct 23	SellUS$12,679,973	Medytox Korea Co. Ltd	Company	1,690,663	US$7.50
16 Aug 23	SellUS$151,770	David Moatazedi	Individual	14,778	US$10.27
16 Aug 23	SellUS$22,707	Sandra Beaver	Individual	2,211	US$10.27
16 Aug 23	SellUS$22,707	Rui Avelar	Individual	2,211	US$10.27
15 Aug 23	BuyUS$1,296,505	Vikram Malik	Individual	174,967	US$7.41
27 Jul 23	SellUS$20,103,297	Alphaeon 1 LLC	Company	2,553,772	US$10.27

Insider Trading Volume

Insider Buying: EOLS insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of EOLS?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,391,760	2.26%
Public Companies	3,136,869	5.1%
Private Companies	3,391,202	5.51%
VC/PE Firms	3,963,424	6.44%
General Public	5,969,296	9.71%
Hedge Funds	8,430,403	13.7%
Institutions	35,214,668	57.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9%.

Top Shareholders

Top 25 shareholders own 75.46% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.67%	Stonepine Capital Management LLC	5,333,004	US$62.5m	2.97%	29.93%
6.44%	Perceptive Advisors LLC	3,963,424	US$46.5m	167%	1.08%
5.5%	Medytox Korea Co. Ltd	3,381,326	US$39.6m	-33.3%	no data
5.43%	BlackRock, Inc.	3,339,377	US$39.1m	12.3%	no data
5.1%	Daewoong Pharmaceutical Co., Ltd	3,136,869	US$36.8m	0%	no data
5.04%	Tang Capital Management, LLC	3,097,399	US$36.3m	0%	4.13%
4.79%	The Vanguard Group, Inc.	2,943,512	US$34.5m	9.07%	no data
4.73%	Nantahala Capital Management, LLC	2,910,849	US$34.1m	591%	3.3%
4.15%	Morgan Stanley, Investment Banking and Brokerage Investments	2,550,818	US$29.9m	453%	no data
3.25%	Great Point Partners, LLC	2,000,000	US$23.4m	-8.55%	3.36%
2.3%	Deutsche Asset & Wealth Management	1,414,526	US$16.6m	6,660%	0.01%
2.14%	Caligan Partners, LP	1,317,856	US$15.4m	-21.7%	4.7%
1.89%	Schroder Investment Management North America Inc.	1,161,738	US$13.6m	-33.7%	0.05%
1.71%	Medical Strategy GmbH, Asset Management Arm	1,051,641	US$12.3m	0%	0.75%
1.67%	State Street Global Advisors, Inc.	1,026,374	US$12.0m	4.25%	no data
1.63%	Millennium Management LLC	1,003,617	US$11.8m	-12.7%	0.01%
1.52%	Geode Capital Management, LLC	934,276	US$10.9m	7.45%	no data
1.5%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	921,501	US$10.8m	-27.6%	no data
1.47%	Rice Hall James & Associates, LLC	906,195	US$10.6m	-18%	0.65%
1.36%	Boothbay Fund Management, LLC	836,925	US$9.8m	-28%	0.41%
1.19%	UBS Asset Management AG	733,032	US$8.6m	-12.3%	no data
1.15%	D. E. Shaw & Co., L.P.	708,538	US$8.3m	43.5%	0.01%
1.02%	AWH Capital, L.P.	629,240	US$7.4m	-24%	6.94%
0.9%	Marshall Wace LLP	553,526	US$6.5m	-18%	0.01%
0.89%	Soros Fund Management LLC	550,000	US$6.4m	0%	0.2%